SAB Biotherapeutics Approves Appointment of Andrew Moin 

SAB also announces closing of $7.5 million financing, the first tranche of $130 million private placementSIOUX FALLS, S.D., Oct. 05, 2023 -- SAB Biotherapeutics ; class='js-l-obf link...

Related Keywords

New York , United States , Andrew Moin , Samuelj Reich , Marshall Wace , Company Board Of Directors , Harvard Law School , Rd Fund , Amherst College , Biotherapeutics Inc , Exchange Commission , Tax Group At Sullivan Cromwell , Sessa Capital , Young Leadership Committee , New York City Chapter , Tax Group , Executive Chairman , Commodore Capital , Private Securities Litigation Reform Act , Markets ,